Shimojima Keiko, Yamamoto Toshiyuki
Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.
Tokyo Women's Medical University Institute for Integrated Medical Sciences, Tokyo, Japan.
Hum Genome Var. 2017 Sep 14;4:17037. doi: 10.1038/hgv.2017.37. eCollection 2017.
Genomic copy number variations (CNVs) identified through chromosomal microarray testing must be validated to confirm whether they are pathogenically and functionally relevant to their respective clinical features. Although larger deletions have a higher probability to be pathogenic, this is not always true. Phenotypically normal individuals showed five CNV deletions larger than 1.5 Mb. The genes related to autosomal dominant trait were absent within these CNV deletions.
通过染色体微阵列检测识别出的基因组拷贝数变异(CNV)必须进行验证,以确认它们在致病性和功能上是否与其各自的临床特征相关。虽然较大的缺失具有更高的致病可能性,但情况并非总是如此。表型正常的个体显示出5个大于1.5 Mb的CNV缺失。这些CNV缺失中不存在与常染色体显性性状相关的基因。